Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced the grant ...
Millennials and Gen Z don't invest the same way their parents did.
Products, Services, and Software for Brokers and Lenders Yesterday this Commentary mentioned a guide titled, “AI in the ...
China Europe International Business School unveils its five-year Strategic Plan (2026–30) on its Shanghai campus on April 9. ...
Discover effective strategies to optimize the asset mix in your investment portfolio, focusing on achieving balance and ...
A total of 551 lots have been finalized for the sale, including 207 racehorses (89 race fillies), 186 broodmares, 76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results